<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01537263</url>
  </required_header>
  <id_info>
    <org_study_id>2371</org_study_id>
    <nct_id>NCT01537263</nct_id>
  </id_info>
  <brief_title>Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage</brief_title>
  <acronym>PSAB</acronym>
  <official_title>Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asklepios Kliniken Hamburg GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asklepios Kliniken Hamburg GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine wether delayed cerebral ischemia can be predicted by
      ultrasound brain perfusion imaging in patients with aneurysmal subarachnoid hemorrhage (SAH).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The delayed cerebral ischemia is a main complication in patient with aneurysmal subarachnoid
      hemorrhage which causes neurological deficit. So far there is no reliable diagnostic tool to
      predict the appearance of cerebral ischemia.

      The causal correlation between presence of cerebral vasospasm measured daily by transcranial
      Doppler sonography (TCD) and occurrence of cerebral ischemia detected by cranial computed
      tomography scan (CCT) is not finally verified.

      First studies demonstrated that ultrasound perfusion imaging (UPI) allows the detection of
      perfusion deficits in middle cerebral artery infarction.

      The purpose of our study is to evaluate the diagnostic and prognostic value of UPI to predict
      delayed cerebral ischemia. In our trial we compare parameters of UPI (b= rise rate, A=
      plateau of acoustic intensity) in patients with aneurysmal subarachnoid hemorrhage with
      results of follow-up cranial computed tomography scans (CCT), TCD results and clinical
      outcome.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of perfusion</measure>
    <time_frame>Baseline, Day 5</time_frame>
    <description>Detection of hypoperfusion (defined by 50% or more reduction in beta-value of comparing day 1. with day 5.) in one or more of four regions in one or both hemispheres before the detection of delayed ischemia after SAH in CCT.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between perfusion parameters, clinical course and flow velocities</measure>
    <time_frame>Day 1 to 90</time_frame>
    <description>Correlation between perfusion parameters (beta- and A-value), clinical course (National Institute of Health Stroke Scale - NIHSS) and flow velocities in the middle and posterior cerebral artery from day 1 to day 90.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Perfusion</measure>
    <time_frame>Baseline, Day 5</time_frame>
    <description>Detection of hypoperfusion (defined by 50% or more reduction in A-value of comparing day 1. with day 5.) in one or more of four regions in one or both hemispheres before the detection of delayed ischemia after SAH in CCT.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aneurysmal Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Ultrasound Perfusion Imaging</arm_group_label>
    <description>Patient with subarachnoid hemorrhage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound Perfusion Imaging</intervention_name>
    <description>Sonographic unit Phillips IU 22, 5ml SonoVue ultrasound contrast agent per examination, Duration: 1h</description>
    <arm_group_label>Ultrasound Perfusion Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aneurysmal subarachnoid hemorrhage, Hunt and Hess 0-5

          -  Informed consent

          -  Sufficient transtemporal acoustic window

          -  First examination within 48h after subarachnoid hemorrhage

          -  Minimum Age 18 years

        Exclusion Criteria:

          -  Contraindication against computed tomographic scan

          -  Incompatibility against SonoVue™

          -  Acute respiratory distress syndrome

          -  Uncontrollable hypertensive crisis

          -  Severe pulmonary disease(pulmonary hypertension &gt; 90 mmHg)

          -  acute severe cardiac insufficiency (New York Heart Association IV)

          -  known right-left-shunt

          -  pregnancy and breastfeeding

          -  Substance dependence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Günter Seidel, MD, Professor of Neurology</last_name>
    <role>Study Director</role>
    <affiliation>Asklepios Kliniken Hamburg GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Günter Seidel, MD, Professor of Neurology</last_name>
    <phone>0049(0)401818873076</phone>
    <email>g.seidel@asklepios.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology, Asklepios Hospital North</name>
      <address>
        <city>Hamburg</city>
        <zip>22417</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Günter Seidel, MD, Professor of Neurology</last_name>
      <phone>0049(0)40 1818873076</phone>
      <email>g.seidel@asklepios.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2012</study_first_submitted>
  <study_first_submitted_qc>February 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2012</study_first_posted>
  <last_update_submitted>April 5, 2012</last_update_submitted>
  <last_update_submitted_qc>April 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asklepios Kliniken Hamburg GmbH</investigator_affiliation>
    <investigator_full_name>Gunter Seidel, MD</investigator_full_name>
    <investigator_title>MD, Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>Aneurysmal Subarachnoid Hemorrhage</keyword>
  <keyword>SAB</keyword>
  <keyword>SAH</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Perfusion imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

